Short Description Alnylam Pharmaceuticals develops sirna‑based drugs to support healthy longevity.
Description Alnylam Pharmaceuticals is a biotechnology innovator targeting the fundamental mechanisms of aging through sirna‑based drugs. The company leverages advancements in rnai therapeutics and collaborates with leading institutions to translate cutting‑edge science into practical interventions. By focusing on science‑backed solutions, Alnylam Pharmaceuticals aims to extend healthspan and improve quality of life across the globe.
Address 675 W Kendall St, Cambridge, MA, USA